BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35119298)

  • 21. The hidden costs of employee drinking: A quantitative analysis.
    Sullivan T; Edgar F; McAndrew I
    Drug Alcohol Rev; 2019 Jul; 38(5):543-553. PubMed ID: 31170328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annual indirect costs secondary to headache disability in Brazil.
    Oliveira AB; Queiroz LP; Sampaio Rocha-Filho P; Sarmento EM; Peres MF
    Cephalalgia; 2020 May; 40(6):597-605. PubMed ID: 31757169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
    Shafer LA; Shaffer S; Witt J; Nugent Z; Bernstein CN
    Inflamm Bowel Dis; 2022 Aug; 28(8):1189-1197. PubMed ID: 34636400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Productivity costs decrease after endoscopic sinus surgery for refractory chronic rhinosinusitis.
    Rudmik L; Smith TL; Mace JC; Schlosser RJ; Hwang PH; Soler ZM
    Laryngoscope; 2016 Mar; 126(3):570-4. PubMed ID: 26371457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
    Holko P; Kawalec P; Mossakowska M; Pilc A
    PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost and impact of health conditions on presenteeism to employers: a review of the literature.
    Schultz AB; Chen CY; Edington DW
    Pharmacoeconomics; 2009; 27(5):365-78. PubMed ID: 19586075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria?
    Jones C; Verstappen SMM; Payne K
    Appl Health Econ Health Policy; 2019 Oct; 17(5):591-613. PubMed ID: 30937837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and subjects without RA.
    Braakman-Jansen LM; Taal E; Kuper IH; van de Laar MA
    Rheumatology (Oxford); 2012 Feb; 51(2):354-61. PubMed ID: 22179729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Productivity loss due to overweight and obesity: a systematic review of indirect costs.
    Goettler A; Grosse A; Sonntag D
    BMJ Open; 2017 Oct; 7(10):e014632. PubMed ID: 28982806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examining the association of smoking with work productivity and associated costs in Japan.
    Suwa K; Flores NM; Yoshikawa R; Goto R; Vietri J; Igarashi A
    J Med Econ; 2017 Sep; 20(9):938-944. PubMed ID: 28685629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States.
    Patel JG; Nagar SP; Dalal AA
    Int J Chron Obstruct Pulmon Dis; 2014; 9():289-300. PubMed ID: 24672234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review.
    Kigozi J; Jowett S; Lewis M; Barton P; Coast J
    Value Health; 2017 Mar; 20(3):496-506. PubMed ID: 28292496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost of Cigarette Smoking‒Attributable Productivity Losses, U.S., 2018.
    Shrestha SS; Ghimire R; Wang X; Trivers KF; Homa DM; Armour BS
    Am J Prev Med; 2022 Oct; 63(4):478-485. PubMed ID: 35909028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.
    Kotseva K; Gerlier L; Sidelnikov E; Kutikova L; Lamotte M; Amarenco P; Annemans L
    Eur J Prev Cardiol; 2019 Jul; 26(11):1150-1157. PubMed ID: 30955367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of migraine and probable migraine on productivity loss in Korea: A cross-sectional online survey.
    Kim Y; Han S; Suh HS
    PLoS One; 2022; 17(11):e0277905. PubMed ID: 36441801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers.
    Nagata T; Mori K; Ohtani M; Nagata M; Kajiki S; Fujino Y; Matsuda S; Loeppke R
    J Occup Environ Med; 2018 May; 60(5):e273-e280. PubMed ID: 29394196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic burden of urgency urinary incontinence in the United States: a systematic review.
    Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I
    J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ill health and distraction at work: Costs and drivers for productivity loss.
    Bialowolski P; McNeely E; VanderWeele TJ; Weziak-Bialowolska D
    PLoS One; 2020; 15(3):e0230562. PubMed ID: 32231382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study.
    Gisbert JP; Cooper A; Karagiannis D; Hatlebakk J; Agréus L; Jablonowski H; Nuevo J
    Health Qual Life Outcomes; 2009 Oct; 7():90. PubMed ID: 19835583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating the economic burden of migraine on US employers.
    Yucel A; Thach A; Kumar S; Loden C; Bensink M; Goldfarb N
    Am J Manag Care; 2020 Dec; 26(12):e403-e408. PubMed ID: 33315334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.